FACTORx
  • HOME
  • ABOUT US
  • FORMATS
  • RESEARCH SERVICES
  • CASE STUDIES
  • IN THE NEWS
FACTORx
  • HOME
  • ABOUT US
  • FORMATS
  • RESEARCH SERVICES
  • CASE STUDIES
  • IN THE NEWS

Supplemental audience generation / potential patient impact factor results

Topic: Hypertension 

Target Audience: Primary Care Providers who treat hypertension patients 

Supplemental Audience Generation E-mail Campaign Selection Criteria: Identify the 10,000 primary care providers, who are in the best position to impact patient care based on specific prescription and patient profile criteria. 

Outcome: A small percentage of learners from our supplemental audience generation campaign completed the CME activity for certification, those clinicians managed/treated more than 96,661 patients who had already been diagnosed with hypertension and been prescribed a hypertensive agent. 

Contact us to find out how many learners manage 96,661 hypertension patients, we think you’ll be surprised.

Audience identification / Generation / POTENTIAL PATIENT IMPACT FACTOR

Topic: Metastatic Hormone-Sensitive Prostate Cancer: Benefits and Risks of Current and Emerging Treatment Options

Target Audience: Hematologists, Oncologists and Urologists  

Supplemental Audience Generation E-mail Campaign Selection Criteria: Clinicians were identified based on the number of metastatic hormone sensitive prostate cancer diagnoses and patient treatments they made over the last year. We identified 787 clinicians who met the diagnostic selection criteria and they managed 270,723 patient diagnoses in the last year. In addition, we also identified 18,058 clinicians who met the treatment criteria and those clinicians managed a minimum of 185,665 patient treatments in the last year. Due to budgetary constraints, an audience generation plan was developed to invite the most active 7,500 clinicians since they’re in the best position to impact patient care.

Outcome: 95 of the completers were confirmed as ‘active treaters’ since they currently had hormone sensitive prostate cancer patients under their care. Those 95 treaters managed 9,262 (avg.97.5) validated hormone sensitive prostate cancer patient treatments in the last year. The participants managed 61.25% more annual patient treatments than their most active colleagues.

Contact us for more information if the initiatives that you're supporting aren't delivering these type of insights

PATIENT EXPERIENCE SURVEY FOCUSED ON IDENTIFYING DISPARITIES IN CARE IN IBD

Topic: Identifying and Overcoming Disparities in IBD Care
Patient Survey

Goal/Aim: Ulcerative colitis (UC) and Crohn’s disease (CD) are chronic inflammatory bowel diseases (IBD) with unclear etiologies. Studies have shown that geographical location and racial differences can affect the diagnosis and reported prevalence of these conditions. The purpose of this patient survey was to assess the disparities in care between White patients and Black patients in the US. The results of the survey were used to inform a panel discussion between IBD patients and IBD experts to raise awareness of racial and ethnic disparities in diagnosis and care management, and to discuss potential solutions that will provide better outcomes for IBD patients.

Target Audience: IBD patients of various racial and ethnic backgrounds  

Outcome: Approximately 2000 patients accessed the survey email. The survey respondent rate was nearly 25%, with data from 455 patients who completed the survey included in this analysis. The mean age of survey respondents was 53 years (range 18-85 years). Eighty-nine percent were female. Of those completing the survey 415 (91.2%) were White and 40 (8.8%) were Black. These findings identified opportunities to improve patient-provider communications and outcomes among Black patients with IBD. Opportunities to overcome disparities for Black patients with IBD include improving communication, shared decision-making, providing patient-friendly/accessible resources, and referral of patients to supplemental resources as needed. The results of this initiative were presented as an abstract at the 2023 annual meeting of the American College of Gastroenterology.

Audience identification / Generation / performance improvement outcomes

Topic: Rheumatoid Arthritis 

Target Audience: Primary Care Providers who diagnose and refer at the lowest frequency (under-performers) 

Claims Database Selection Criteria: Primary Care Provider, <7 Dx of RA over last 14 months, fewest # of shared patients (referral rates), high % of female patients ages 25-55 and/or male patients 50-55, none of whom have been diagnosed with RA. 

Output:  Identified 61,382 primary care providers who currently managed/treated 17,748,309 patients living at higher risk for RA. 

Outcome: 1,691 of our CME participants currently manage/treat 265,834 of the 17,748,309 patient pool identified in our baseline analysis, yielding 1,837 newly diagnosed RA patients 2.5+ years post-activity. 

Contact us for information on how we reached 61,382 clinicians identified as being in the best position to impact patient care.

performance improvement type initiatives

Topic: Rheumatoid Arthritis 

Target Audience: Primary Care Providers (National audience) 

Curriculum: Multi-platform based curriculum focused on the benefits of an early diagnosis, appropriate referral to a specialist and long-term co-management strategies. 

Proposed Measure: To measure the referral trends amongst CME participants 4 months, pre/post intervention and compare them against a control group. 

Outcome: Of the 531 CME participants for whom we were able to match against the national-scope medical claims database, we were able to identify a relative 11.8% increase in the number of referrals they made 4 months post-intervention, compared to no increase/decrease observed in the control group. 

If you’re familiar with claims data, you know it’s almost impossible to track an actual referral……Contact us to find out how we did it.

potential patient impact factor analysis

Topic: Overactive Bladder (OAB)

Objective: Determine how many OAB patients who had been previously diagnosed and been prescribed an appropriate medication are currently being treated by the participants of a CME initiative. 

Methodology: There were 2,324 participants for the live and enduring CME activities who stated they would commit to a positive practice change or that their practice patterns were already consistent with the curriculum. 2,002 (86% match rate) of whom we were able to match against the national scope medical claims database. Through an analysis of ICD-9 codes and prescription data, we were able to determine how many patients with OAB these 2,002 clinicians currently manage/treat to objectively determine the minimum number of patients who would potentially be impacted by these CME interventions. Of the 2,002 providers, 1,004 were currently managing/treating OAB patients and had written at least one prescription for an OAB medication in the last twelve months. 

Outcome: Based on an analysis of the medical claims database, we were able to identify 1,004 (out of 2,002) primary care providers who currently manage/treat 6,403 validated OAB patients or an average of 6.38 OAB patients/provider. 

If you’d like to know how these numbers stack up against the national average, please contact us.

     STEVE BENDER, PRESIDENT

sbender@gofactorx.com

484-354-4816


Copyright © 2024 FACTORx - All Rights Reserved